Cytosorbents CorporationCTSONASDAQ
Loading
Total debt minus cash and cash equivalents
5Y CAGR
+40.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.5x
Strong expansion
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $23.61M | +464.6% |
| 2023 | $4.18M | +207.4% |
| 2022 | $-3.89M | +89.8% |
| 2021 | $-38.32M | +45.6% |
| 2020 | $-70.39M | -1730.2% |
| 2019 | $4.32M | +134.7% |
| 2018 | $-12.43M | -69.6% |
| 2017 | $-7.33M | -2097.6% |
| 2016 | $-333531.00 | +93.7% |
| 2015 | $-5.32M | - |